€
ꢀ
E.G. Doyaguez, A. Fernandez-Mayoralas / Tetrahedron 68 (2012) 7345e7354
7350
was stirred for 48 h at room temperature. Then, solvent was evapo-
rated under reduced pressure, and acetone was added over the res-
idue obtained, giving a white precipitate that was filtered and
washed with acetone. The precipitate was purified by flash chro-
matography (MeCN/H2O 5:1) obtaining 12 (0.177 g, 85%) as a white
4.3e4.2 (m, 1H), 4.0e3.9 (m, 1H), 3.7e3.4 (m, 28H), 3.4e3.2 (m,
overlaps with HOD), 3.1e3.0 (m, 1H), 2.9e2.8 (m, 1H), 2.4e2.2(m,
1H), 2.0e1.9 (m, 1H); 13C NMR (125 MHz, DMSO-d6):
d 172.2, 153.6,
144.1, 136.5e136.0, 129.5e126.3, 125.9, 102.2, 81.4, 79.8, 73.9e72.0,
75.1, 66.2, 61.2, 60.1, 57.6, 50.2, 30.7. HRMS (ESI) m/z (%) calcd for
C65H93N4O39 [MþH]þ: 1553.5417, found: 1553.5534.
foam. ½a 2D5
ꢀ
þ58.6 (c 0.5, DMSO-d6); 1H NMR (400 MHz, DMSO-d6):
d
7.4e7.2 (m, 10H), 5.8e5.6 (m, 14H), 5.2e5.0 (m, 4H), 4.9e4.8 (m,
7H), 4.6e4.4 (m, 6H), 4.3e4.2 (m, 1H), 4.2e4.1 (m, 1H), 3.8e3.4 (m,
28H), 3.4e3.2 (m, overlaps with HOD), 3.2e3.1 (m, 2H), 2.6e2.5 (m,
1H), 2.4e2.2(m, 4H),1.9e1.8 (m,1H); 13C NMR (100 MHz, DMSO-d6):
4.8. 6I-[[(2S,4R)-2-Carboxypyrrolidin-4-yl]4-oxymethyl]-1H-
1,2,3-triazol-1-yl-6I-deoxy-
b-cyclodextrin (3)
d
172.2,171.7,171.5,153.5,136.6e135.9,128.4e128.3,101.9, 83.4, 81.6,
To a suspension of 15 (250 mg, 0.161 mmol) in water (6 mL)
PdeC (10%, 51.2 mg) was added. The mixture was stirred under H2
(45 psi) in a Parr reactor for 48 h at room temperature. Then, Pd was
filtered through Celite and the filtrate was freeze-dried, obtaining 3
81.4, 66.2, 59.9, 59.8, 57.2, 47.0, 40.0, 30.4. HRMS (ESI)m/z (%) calcd for
C66H96N3O40 [MþH]þ: 1570.5570, found: 1570.5585.
4.5. 6I-[N0-(2S,4S)-2-Carboxypyrrolidin-4-yl]
(0.190 g, 89%) as a white foam. ½a D25
ꢀ
þ44.8 (c 0.52, H2O); 1H NMR
aminocarbonylethylcarbonylamino-6I-deoxy-
b-cyclodextrin (2)
(300 MHz, D2O):
d
7.91 (s, 1H), 5.01 (d, J¼3.4 Hz, 1H) 4.9e4.8 (m,
6H), 4.4e4.3 (m,1H), 4.2e4.0 (m,1H), 3.9e3.6 (m, 24H), 3.6e3.3 (m,
20H) 3.1e2.9 (d, 1H, J¼12.1 Hz), 2.7e2.6 (m, 1H), 2.5e2.4 (m, 1H),
To a suspension of 12 (128 mg, 0.081 mmol) in water (10 mL),
PdeC (10%, 25.8 mg) was added. The mixture was stirred under H2
(45 psi) in a Parr reactor for 48 h at room temperature. Then, Pd was
filtered through Celite, and the filtrate was freeze-dried. Compound
2.1e1.9 (m,1H); 13C NMR (125 MHz, DMSO-d6):
d 174.2,143.9,126.9,
102.2, 102.1, 102.0, 101.6, 83.3, 81.5, 81.3, 80.9, 78.0, 73.3e72.0, 71.9,
71.7, 70.7, 61.4, 60.5, 60.1, 59.4, 50.6 (CH2), 35.1. MS (ESI) m/z 1329.9
(MþH); HRMS (ESI) m/z (%) calcd for C50H81N4O37 [MþH]þ:
1329.4580, found: 1329.4563. Anal. Calcd (%) for C50H80N4O37: C,
45.18; H, 6.07; N, 4.22. Found: C, 44.89; H, 6.21; N, 4.18.
a 25
2 was obtained (0.108 g, 100%) as a white foam. ½ ꢀD þ31.2 (c 0.1,
H2O); 1H NMR (400 MHz):
d
4.9e4.8 (m, 7H), 4.26 (q, J¼9.0 Hz, 1H)
3.98 (t, J¼9.0 Hz, 1H), 3.8e3.6 (m, 28H), 3.5e3.3 (m, 14H), 3.3e3.1
(m, 2H), 2.6e2.5 (m, 1H), 2.4e2.2 (m, 4H), 1.8e1.7 (m, 1H); 13C NMR
(100 MHz, D2O):
d
174.5, 173.8, 173.5, 101.8, 81.1, 73.0, 71.9, 71.6,
4.9. 6I-Azido-6I-deoxy-2IeVII,3IeVII,6IIeVII-eicosakis-O-benzyl-
60.3, 57.1, 49.9, 48.9, 40.1, 34.2, 30.6. MS (ESI) m/z 1346.9 [MþH]þ.
Anal. Calcd (%) for C51H83N3O38: C, 45.50; H, 6.21; N, 3.12. Found: C,
45.80; H, 6.03; N, 3.40.
b-cyclodextrin (16)
To a solution of 13 (600 mg, 0.517 mmol) in anhydrous DMSO
(12.6 mL) NaH (0.856 g, 18.6 mmol) was added, and the mixture
was stirred at room temperature for 30 min under Ar atmosphere.
Then, the reaction was cooled at 0 ꢂC and benzyl chloride (2.14 mL,
18.6 mmol) was added. The mixture was stirred for 30 min at 0 ꢂC,
and then at room temperature overnight. Then, 10 mL of water
were added to stop the reaction, and it was extracted with ether
(4ꢃ10 mL) and washed with brine. Organic phases were dried
(Na2SO4) and the solvent was evaporated under reduced pressure.
The residue was purified by flash chromatography (hexane/EtOAc
4.6. (2S,4R)-1,2-Dibenzyloxycarbonyl-4-(prop-2-inyloxy)
pyrrolidine (14)
A
solution of (2S,4R)-1,2-dibenzyloxycarbonyl-4-hydroxypy
rrolidine11 (440 mg, 0.985 mmol) in DMF (3.5 mL), was added
over a suspension of sodium hydride (48 mg, 1.63 mmol) in DMF
(3.5 mL) at ꢁ20 ꢂC under argon atmosphere. The mixture was stir-
red for 20 min and then propargyl bromide (0.205 mL, 1.63 mmol)
was added. The reaction mixture was stirred at ꢁ20 ꢂC for 1 h, and
then it was stirred at room temperature for 16 h. After this time,
MeOH (2.5 mL) was added, and it was extracted with CH2Cl2
(3ꢃ2.5 mL) and washed with brine. The organic phases were dried
(Na2SO4), and the solvent was evaporated under reduced pressure.
The residue was purified by column chromatography (hexane/
EtOAc 4:1). Compound 14 was obtained (0.300 g, 75%) as a colorless
5:1). Compound 16 was obtained (1.16 g, 76%) as a yellow oil. ½a D25
ꢀ
þ57.0 (c 8.2, CH2Cl2); 1H NMR (400 MHz, CDCl3):
d 7.4e7.05 (m,
100H), 5.4e5.3 (m, 1H), 5.3e5.0 (m, 12H), 4.9e4.7 (m, 10H), 4.8e4.3
(m, 24H), 4.2e3.8 (m, 24H), 3.7e3.4 (m, 18H); 13C NMR (100 MHz,
CDCl3):
d
140.8, 139.3e139.2, 139.0, 138.3e137.9, 128.5,
128.4e126.9, 98.7e98.1, 97.8, 80.8e80.6, 79.5e78.7, 76.7e75.1,
73.3e73.2, 72.8e72.5, 71.7e70.7, 69.4e68.9, 65.3. MS (ESI) m/z
2962.9 [MþH]þ. Anal. Calcd (%) for C182H189N3O34: C, 73.79; H, 6.43;
N, 1.42. Found: C, 73.57; H, 6.75; N, 1.17.
oil. ½a 2D5
ꢀ
ꢁ32.4 (c 0.83, CH2Cl2); 1H NMR (400 MHz, CDCl3):
d 7.4e7.2
(m, 10H), 5.3e5.0 (m, 4H), 4.6e4.4 (m, 1H), 4.4e4.3 (m, 1H), 4.2e4.1
(m, 2H), 3.8e3.6 (m, 2H), 2.5e2.3 (m, 2H), 2.2e2.0 (m,1H); 13C NMR
(100 MHz, CDCl3):
d
172.2, 162.5, 128.5e127.8, 79.1, 76.2, 75.5, 77.1,
4.10. 6I-Amino-6I-deoxy-2IeVII,3IeVII,6IIeVII-eicosakis-O-
benzyl-b-cyclodextrin (17)
66.9, 58.0, 56.3, 51.6, 35.2. MS (ESI) m/z 394.2 [MþH]þ, 416.2
[MþNa]þ. Anal. Calcd (%) for C23H23NO5: C, 70.21; H, 5.89; N, 3.56.
Found: C, 69.82; H, 6.15; N, 3.58.
To a solution of 16 (970 mg, 0.327 mmol) in THF (9.34 mL), PMe3
(solution 1 M in THF; 3.93 mL, 3.93 mmol) and H2O (2.33 mL) were
added. The reaction mixture was stirred at 50 ꢂC for 24 h. Then
solvent was evaporated under reduced pressure, and the residue
was extracted with EtOAc and water (3ꢃ25 mL). Organic phases
were dried (Na2SO4) and the solvent was evaporated under reduced
pressure. The residue was purified by flash chromatography (tolu-
ene/EtOAc 20:1/1:1). Compound 17 was obtained (0.650 g, 70%)
4.7. 6I-[[(2S,4R)-1,2-Dibenzyloxycarbonylpyrrolidin-4-yl]4-
oxymethyl]-1H-1,2,3-triazol-1-yl-6I-deoxy-
b-cyclodextrin (15)
To a solution of 13 (500 mg, 0.427 mmol) in DMF/H2O (1:1 (v/v),
20 mL), were added successively 14 (168 mg, 0.427 mmol),
CuSO4$5H2O (80.9 mg, 0.324 mmol), and sodium ascorbate
(57.8 mg, 0.324 mmol). The reaction mixture was heated in the
microwave at 80 ꢂC (200 W) for 5 h. Then, solvent was evaporated
under reduced pressure, and the residue was purified by flash
chromatography (MeCN/H2O 6:1). Compound 15 was obtained
as a white foam. ½a D25
ꢀ
þ54.8 (c 2.9, CH2Cl2); 1H NMR (400 MHz,
CDCl3):
d 7.4e7.05 (m, 100H), 5.3e4.9 (m, 21H), 4.8e4.6 (m, 12H),
4.6e4.2 (m, 28H), 3.7e3.3 (m, 28H), 3.0e2.8 (m, 2H); 13C NMR
(100 MHz, CDCl3): 139.2, 138.3e138.1, 128.3, 128.2e126.9,
d
(0.500 g, 75%) as a white foam. ½a D25
ꢀ
þ57.6 (c 0.5, DMSO-d6); 1H
98.9e98.1, 97.8, 80.9e80.6, 79.5e78.7, 76.7e75.1, 73.3e73.2,
72.8e72.7, 71.6e71.1, 69.2e68.9. HRMS (ESI) m/z (%) calcd for
C182H192NO34 [MþH]þ: 2935.3326, found: 2935.3306. Anal. Calcd
NMR (500 MHz, DMSO-d6):
d 8.1e7.9 (m, 1H), 7.4e7.2 (m, 10H),
5.8e5.6 (m,14H), 5.2e5.0 (m, 4H), 4.9e4.8 (m, 7H), 4.6e4.4 (m, 8H),